Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

One in seven students has dabbled in “smart” drugs

14.11.2013
One in seven Swiss students has already tried to enhance his or her performance with pre-scription medication or drugs. Besides psychostimulants like Ritalin, students also consume sedatives, alcohol or cannabis.

These substances are mostly only taken during the exam preparation period. Only a narrow majority of polled students reported the desired effects, as a representative study conducted by researchers at the universities of Zurich and Basel reveals.


Besides psychostimulants like Ritalin, students also consume sedatives, alcohol or cannabis.
UZH

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

Majority consumes soft enhancers

Around 94 percent of the students surveyed had already heard of neuroenhancement. 13.8 percent of these students had tried to improve their cognitive performance with prescription medication or legal or illegal drugs at least once during their degrees. The substance most used was alcohol (5.6%), fol-lowed by methylphenidate such as Ritalin (4.1%), sedatives and soporifics (2.7%), cannabis (2.5%), beta-blockers (1.2%), amphetamines (0.4%), and cocaine (0.2%).

The respondents primarily took these substances during the exam preparation period, only consum-ing stimulating substances rarely in the exam situation or for general stress during their degrees. While daily neuroenhancement was a rare occurrence (1.8%), the majority consumed “soft enhancers” such as caffeinated products, non-prescription vitamin products or herbal sedatives before their last big exam – around a third even every day.

The number of Swiss students who take neuroenhancing drugs is comparable with recent studies conducted at European universities. “The purported frequency of neuroenhancement at Swiss univer-sities needs to be put into perspective as we asked about psychoactive and calmative substances,” says PD Michael Schaub, the study leader and head of the Swiss Research Institute for Public Health and Addiction.

Narrow majority obtained desired effect

As a rule, advanced students who also had a job alongside their degrees and reported higher stress levels consumed performance-enhancing substances more frequently. Certain differences were ap-parent depending on the degree course: In Switzerland, students of the subjects architecture (19.6%), journalism (18.2%), chemistry (17.6%), economics (17.1%), medicine (16.2%), or pharmaceutics (16.1%) had more experience of neuroenhancement than budding mathematicians (8.6%) or sports students (7%), for instance.

According to the survey, the intended effect was only achieved in a narrow majority of the students, which is why only around half would actually take these substances to boost their brain power again. “The development of neuroenhancement at Swiss universities should be monitored as students con-stitute a high-risk group that is exposed to increased stress and performance pressure during their degrees,” concludes Schaub. “However, there is no need to intervene as yet.”

Literature:

Larissa J. Maier, Matthias E. Liechti, Fiona Herzig, Michael P. Schaub. To dope or not to dope: Neu-roenhancement with prescription drugs and drugs of abuse among Swiss university students. PLOS ONE. Doi:10.1371/journal.pone.0077967

Background

Within the scope of the study at the universities of Zurich and Basel and ETH Zurich, 28,118 stu-dents were contacted, 6,275 of whom went on to take part in the online survey. The study was con-ducted by the Swiss Research Institute for Public Health and Addiction, an associate institute of the University of Zurich, and the Division of Clinical Pharmacology at the University Hospital Basel.

Contact:

PD Dr. phil. Michael Schaub
ISGF Swiss Research Institute for Public Health and Addiction Zurich
University of Zurich
Tel. +41 44 448 11 65
E-Mail: michael.schaub@isgf.uzh.ch

Beat Müller | Universität Zürich
Further information:
http://www.uzh.ch
http://www.mediadesk.uzh.ch/articles/2013/jeder-siebte-student-hat-schon-gedopt.html

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>